Role of telomerase in cellular proliferation and cancer

Journal of Cellular Physiology

Volumn 180, Issue 1, 1999, Pages 10-18

  Holt, Shawn E ^a   Shay, Jerry W ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

CANCER; CELL CYCLE; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ACTIVITY; GENETIC STABILITY; HUMAN; LIFESPAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIVISION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM CELLS; HUMANS; NEOPLASMS, EXPERIMENTAL; TELOMERASE; TELOMERE;

EID: 0033004686     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D     Document Type: Review

References (104)

1. Albanell J, Han W, Mellado B, Gunawardane R, Scher HI, Dmitrovsky E, Moore MAS. 1996. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 56:1503-1508.
2. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Youglai EV, Futcher AB, Greider CW, Harley CB. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118.
3. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650.
4. Beattie TL, Zhou W, Robinson MO, Harrington L. 1998. Reconstitution of human telomerase in vitro. Curr Biol 8:177-180.
5. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT. 1996. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 56:3796-3802.
6. Bisoffi M, Chakerian AE, Fore ML, Bryant JE, Hernandez JP, Moyzis RK, Griffith JK. 1998. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA. Eur J Cancer 34:1242-1249.
7. Blackburn EH. 1992. Telomerases. Annu Rev Biochem 61:113-129.
8. Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
9. Bodnar AG, Kim NW, Effros RB, Chiu C-P. 1996. Mechanism of telomerase induction during T cell activation. Exp Cell Res 228:58-64.
10. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
11. Broccoli D, Young JW, de Lange T. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92:9082-9086.
12. Buchkovich KJ, Greider CW. 1996. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 7:1443-1454.
13. Chui C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM. 1996. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14:239-248.
14. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. 1995. Telomerase activity in normal leukocytes and in hematological malignancies. Blood 85:2315-2320.
15. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA. 1998a. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16:1217-1222.
16. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA. 1998b. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 95:14723-14728.
17. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr. 1997. Solid cancers after bone marrow transplantation. N Engl J Med 336:897-905.
18. Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriot A, Khoudoli G, Parkinson EK, Cooper CS, Newbold RF. 1999. Telomerase repressor sequences on chromosome 3 and induction of permanent growth-arrest in human breast cancer cells. J Natl Cancer Inst 91:37-45.
19. Dalbagni G, Han W, Zhang Z-F, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MAS. 1997. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 3:1593-1598.
20. de Lange T, Shiue L, Meyers RM, Cox DR, Naylor SL, Killery AM, Varmus HE. 1990. Structure and variability of human chromosome ends. Mol Cell Biol 10:518-527.
21. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS. 1997. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182-193.
22. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. 1995. The RNA component of human telomerase. Science 269:1236-1241.
23. Harle-Bachor C, Boukamp P. 1996. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93:6476-6481.
24. Harley CB, Futcher AB, Greider CW. 1990. Telomeres shorten with aging. Nature 345:458-460.
25. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program, Bass MB, Arruda I, Robinson MO. 1997a. A mammalian telomerase-associated protein. Science 275:973-977.
26. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, Mar V, Bass MB, Robinson MO. 1997b. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11: 3109-3115.
27. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. 1990. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868.
28. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. 1995a. Correlation of telomerase activity level with human neuroblastoma outcomes. Nature Med 1:249-257.
29. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek M, Shay JW, Matsuura Y. 1995b. Telomerase activity in gastric cancer. Cancer Res 55:3258-3262.
30. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. 1995c. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715.
31. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, Yokoyama T. 1996a. Telomerase activity in human intestine. Int J Oncol 9:453-458.
32. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW. 1996b. Telomerase activity in human breast tumors. J Natl Cancer Inst 88:116-122.
33. Holt SE, Wright WE, Shay JW. 1996. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16:2932-2939.
34. Holt SE, Aisner DL, Shay JW, Wright WE. 1997a. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 94:10687-10692.
35. Holt SE, Wright WE, Shay JW. 1997b. Multiple pathways for the regulation of telomerase activity. Eur J Cancer 33:761-766.
36. Horikawa I, Oshimura M, Barrett JC. 1998. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinogen 22:65-72.
37. Igarashi H, Sakaguchi N. 1997. Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89:1299-1307.
38. Jiang Z-R, Jimenez G, Chang E, Frolkis M, Busler B, Sage M, Beeche M, Bodnar AG, Wahl GA, Tlsty TD, Chui C-P. 1999. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-114.
39. Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H. 1998. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21waf1 gene expression. Mol Carcinogen 21:26-36.
40. Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA. 1997. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019.
41. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
42. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, Yamada H, Terachi T, Yoshida O. 1997. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 89:724-730.
43. Kipling D, Cooke HJ. 1990. Hypervariable ultra-long telomeres in mice. Nature 347:400-402.
44. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. 1998. Both Rb/p16ink4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88.
45. Kondo S, Kondo Y, Li G, Silverman RH, Cowell JK. 1998. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16:3323-3330.
46. Kyo S, Takakura M, Kohama T, Inoue M. 1997. Telomerase activity in human endometrium. Cancer Res 57:610-614.
47. Lee H-W, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-574.
48. Leteurtre F, Li X, Gluckman E, Carosella ED. 1997. Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia 11:1681-1689.
49. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y. 1996. Telomerase activity in human bladder cancer. Clin Cancer Res 2:929-932.
50. Lindsey J, McGill N, Lindsey L, Green D, Cooke H. 1991. In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48.
51. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. 1997. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:561-567.
52. Mantell LL, Greider CW. 1994. Telomerase activity in germline and embryonic cells of Xenopus. EMBO J 13:3211-3217.
53. Mehle C, Lindblom A, Ljungberg B, Stenling R, Roos G. 1998. Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int J Cancer 13:289-295.
54. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795.
55. Morales CP, Holt SE, Ouellette M, Kaur K, Yan Y, Wilson KS, White MA, Wright WE, Shay JW. 1999. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21:115-118.
56. Morrison SJ, Prowse KR, Ho P, Weissman IL. 1996. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207-216.
57. Moyzis RK, Buckingham JM, Cram S, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu J-R. 1988. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622-6626.
58. Nakamura TM, Morin GB, Chapman B, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. 1997. Telomerase catalytic subunit homologs from fission yeast and humans. Science 277:955-959.
59. Nakayama J-I, Saito M, Nakamura H, Matsuura A, Ishikawa F. 1997. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeat family. Cell 88:1-20.
60. Norrback K-F, Dahlenborg K, Carlsson R, Roos G. 1996. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88:222-229.
61. Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR. 1996. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnol 14:615-619.
62. Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L. 1997. In vivo dynamics of human hematopoietic stem cells. Proc Natl Acad Sci USA 94:13782-13785.
63. Ohmura H, Tahara H, Suzuki M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M. 1995. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86:899-904.
64. Olovnikov AM. 1971. Principle of marginotomy in template synthesis of polynucleotides. Doklady Biochem 201:394-397.
65. Ouellette MM, Aisner DL, Savre-Train I, Wright WE, Shay JW. 1999. Telomerase activity does not always imply telomere maintenance. Biochem Biophys Res Commun 254:795-803.
66. Palmer LD, Weng N-P, Levine BL, June CH, Lane HC, Hodes RJ. 1997. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins. J Exp Med 185:1381-1386.
67. Pan C, Xue B-H, Ellis TM, Peace DJ, Diaz MO. 1997. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 231:346-353.
68. Piatyszek MA, Kim NW, Weinrich SL, Keiko H, Hiyama E, Wright WE, Shay JW. 1995. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17:1-15.
69. Pitts A, Corey DR. 1998. Inhibition of human telomerase by 2'-O-methyl-RNA. Proc Natl Acad Sdi USA 95:11549-11554.
70. Ramirez RD, Wright WE, Shay JW, Taylor RS. 1997. Telomerase activity concentrated in the mitotically active segments of human hair follicles. J Invest Dermatol 108:113-117.
71. Reichman TW, Albanell J, Wang X, Moore MAS, Studzinski GP. 1997. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem 67:13-23.
72. Rheinwald JG, Green H. 1977. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265:421-424.
73. Saito T, Schneider A, Martel N, Mizumoto H, Bulgay-Moerschel M, Kudo R, Nakazawa H. 1997. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biophys Res Commun 231:610-614.
74. Savoysky E, Yoshida K, Ohtomo T, Yamaguchi Y, Akamasu K, Yamazaki T, Yoshida S, Tsuchiya M. 1996. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem Biophys Res Commun 226:329-334.
75. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R. 1995. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92:12343-12346.
76. Shay JW. 1999. Toward identifying a cellular determinant of telomerase repression. J Natl Cancer Inst 91:4-6.
77. Shay JW, Bacchetti S. 1997. A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791.
78. Shay JW, Wright WE. 1989. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184:109-118.
79. Shay JW, Wright WE. 1996. Telomerase activity in human cancer. Curr Opin Oncol 8:66-71.
80. Shay JW, Pereira-Smith OM, Wright WE. 1991. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196:33-39.
81. Strahl C, Blackburn EH. 1996. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16:53-65.
82. Tanaka H, Shimuzu M, Horikawa I, Kugoh H, Yokota J, Barrett JC, Oshimura M. 1998. Evidence for a putative telomerase repressor in the 3p14.2-p21.1 region. Genes Chrom Cancer 23:123-133.
83. Tsao J, Shao Y, Lukas J, Yang X, Shah A, Press M, Shibata D. 1997. Telomerase activity in normal and neoplastic breast. Clin Cancer Res 3:627-631.
84. Vaziri H, Benchimol S. 1998. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8:279-282.
85. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860.
86. Vieten L, Belair CD, Savelieva L, Julicher K, Brocker F, Bardenheuer W, Schutte J, Opalka B, Reznikoff CA. 1998. Minimal deletion of 3p13→14.2 associated with immortalization of human uroepithelial cells. Genes Chrom Cancer 21:39-48.
87. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. 1998. Myc activates telomerase. Genes Dev 12:1769-1774.
88. Watson JD. 1972. Origin of concatameric T4 DNA. Nat New Biol 239:197-201.
89. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB. 1997. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subnit hTRT. Nat Genet 17:498-502.
90. Weng N-P, Granger L, Hodes RJ. 1997a. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 94:10827-10832.
91. Weng N-P, Levine BL, June CH, Hodes RJ. 1997b. Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J Immunol 158:3215-3220.
92. Weng RF, Cross MA, Hatton C, Will AM, Lashford LS, Dexter TM, Testa NG. 1997c. Accelerated telomere shortening in young recipients of allogeneic bone marrow transplants. Lancet 351:178-181.
93. Wheelhouse RT, Sun D, Han H, Han FX, Hurley LH. 1998. Cationic porphyrins as telomerase inhibitors: the interaction of tetra-(n-methyl-4-pyridyl)porphine with quadraplex DNA. J Am Chem Soc 120:3261-3262.
94. Wright WE, Shay JW. 1992. The two-stage mechanism controlling cellular senescence and immortalization. Exp Geron 27:383-389.
95. Wright WE, Pereira-Smith OM, Shay JW. 1989. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9:3088-3092.
96. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. 1996. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179.
97. Xu D, Gruber A, Peterson C, Pisa P. 1996. Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 10:1354-1357.
98. Xu H-J, Shou Y, Ji W, Perng G-S, Kruzelock R, Kong C-T, Bast RC, Mills GB, Li J, Hu S-X. 1997. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15:2589-2596.
99. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T, Utakoji T. 1996. Telomerase activity in normal human epithelial cells. Oncogene 13:433-439.
100. Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Tamaya T. 1998a. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol 68:145-149.
101. Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Wan X, Niwa K, Tamaya T. 1998b. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res 58:5406-5410.
102. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, Fellows G, Goodison S, Tahara E, Tarin D. 1997. Telomerase activity in bladder carcinoma and its implications for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79:362-369.
103. Zhang W, Piatyszek MA, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE, Shay JW. 1996. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 2:799-803.
104. Zhu X, Kumar R, Mandai M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R. 1996. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 93:6091-6095.